Reference
Glossary
The terms that appear most often in research papers, lab reports and vendor product pages, defined in plain language.
Last reviewed: September 2026
AAS
Anabolic-androgenic steroids
- Synthetic derivatives of testosterone. The class studied in most of the long-running human literature on performance-enhancing drug harms.
Ancillary
- A compound taken alongside another to manage its side effects rather than for a performance effect of its own — for example a SERM or aromatase inhibitor used during or after androgen use.
Bacteriostatic water
- Sterile water containing a preservative, sold for reconstituting freeze-dried peptides. Vendors usually treat it as non-returnable once opened.
Bloodwork
Blood panel
- A set of laboratory blood tests used to monitor markers such as lipids, liver enzymes, haematocrit and hormone levels. Interpreting results requires clinical context — training and dehydration alone can move several markers.
COA
Certificate of analysis
- A laboratory document stating the identity and purity of a specific batch. A COA is only as meaningful as the lab that issued it, the batch number it names, and whether that batch is the one you received.
Cloaking
- Showing search engines different content than human visitors see. It is a search-engine policy violation and, on a commerce site, a signal that public claims may not be what buyers experience.
Evidence grade
- Our rating of how strong the published human evidence is for a compound: Moderate, Limited, Very limited, or Preclinical only. It rates the literature, not the compound's safety or desirability.
HPLC
High-performance liquid chromatography
- A laboratory technique used to separate and quantify the components of a sample. In this context it is the method most often cited to support a purity percentage.
HPTA
Hypothalamic-pituitary-testicular axis
- The hormonal feedback loop that regulates natural testosterone production. Exogenous androgens suppress it; recovery time after use varies widely between individuals.
hCG
Human chorionic gonadotropin
- A hormone used clinically in fertility medicine and, outside medical supervision, in attempts to restart suppressed testicular function.
IGF-1
Insulin-like growth factor 1
- A growth factor largely produced in the liver in response to growth hormone. Often measured as a proxy for growth-hormone activity.
LC-MS
Liquid chromatography–mass spectrometry
- An analytical method used to confirm the identity of a compound, often reported alongside HPLC purity figures.
PCT
Post-cycle therapy
- A term used in community settings for compounds taken after androgen use in an attempt to restore natural hormone production. The practice is far less standardised than the name implies and is not a clinical protocol.
PED
Performance-enhancing drug
- Any substance used to improve physical performance or appearance. As used on this site it covers androgens, SARMs, peptides, stimulants and related research chemicals.
Peptide
- A short chain of amino acids. In this market the term covers a wide range of compounds with very different evidence bases, from well-studied therapeutics to substances with no human data at all.
Preclinical
- Research conducted in cells or animals rather than people. Preclinical results indicate a mechanism worth studying; they do not establish that something works or is safe in humans.
RCT
Randomised controlled trial
- A study in which participants are randomly assigned to treatment or control. The strongest common design for establishing whether an effect is caused by the intervention.
Research-use-only
RUO
- A labelling convention stating a product is not for human consumption. It describes how a product is sold, not what it contains or how safe it is.
SARM
Selective androgen receptor modulator
- A compound designed to act on androgen receptors with more tissue selectivity than testosterone. Most SARMs have no completed human safety programme.
SERM
Selective estrogen receptor modulator
- A compound that blocks or activates estrogen receptors depending on the tissue. Used clinically in breast cancer and fertility medicine, and in community settings as an ancillary.
Suppression
- The reduction of natural hormone production caused by taking an exogenous hormone or hormone-like compound. Degree and duration vary by compound, dose and individual.
Supraphysiological
- Above the range the body produces naturally. Much of the recreational-use literature involves supraphysiological doses, which is why therapeutic trial results often do not transfer.
Third-party tested
- Tested by a laboratory independent of the seller. The phrase carries weight only when the laboratory is named and the result is traceable to a batch.
Definitions describe how each term is used in the literature and in this market. They are educational and are not medical advice.
